BIO Technical Analysis
As of date:1/19/2022
BIO stock price:598.44
BIO 50 DMA:728.68
BIO 200 DMA:701.92
BIO MACD (200-50):-26.76
BIO RSI:10.29
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)10.29
Extremely
Oversold

Also see:
BIO Market Cap History
BIO Shares Outstanding History
BIO YTD Return

Try ChartSweeps today
Quotes delayed 20 minutes

Email EnvelopeFree BIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Infineon Technologies (IFNNF) Shares Cross Below 200 DMA
3 hours ago


Gilead Sciences Breaks Below 200-Day Moving Average - Notable for GILD
3 hours, 6 minutes ago


Notable Two Hundred Day Moving Average Cross - BRSP
3 hours, 20 minutes ago


United Natural Foods (UNFI) Shares Cross Below 200 DMA
3 hours, 21 minutes ago


American Assets Trust (AAT) Shares Cross Below 200 DMA
3 hours, 22 minutes ago


Gannett Breaks Above 200-Day Moving Average - Bullish for GCI
3 hours, 22 minutes ago


LFC Makes Bullish Cross Above Critical Moving Average
3 hours, 22 minutes ago


SBSW Makes Bullish Cross Above Critical Moving Average
3 hours, 22 minutes ago


AGS Crosses Above Key Moving Average Level
3 hours, 22 minutes ago


RBA Makes Bullish Cross Above Critical Moving Average
3 hours, 39 minutes ago


RBA.CA Crosses Above Key Moving Average Level
3 hours, 40 minutes ago


Hovnanian Enterprises (HOV) Shares Cross Below 200 DMA
3 hours, 40 minutes ago


CEF Crosses Above Key Moving Average Level
3 hours, 40 minutes ago


CGG.CA Crosses Above Key Moving Average Level
3 hours, 49 minutes ago


Notable Two Hundred Day Moving Average Cross - AROW
21 hours, 31 minutes ago


More Technical Analysis News

BIO Technical AnalysisBIO RSI
Bio-Rad Laboratories is a manufacturer and distributor of its own life science research and clinical diagnostics products. Co.'s business is organized into two reportable segments: Life Science, which develops, manufactures, sells and services reagents, apparatus and instruments used for biological research; and Clinical Diagnostics, which develops, manufactures, sells and services automated test systems, informatics systems, test kits and quality controls for the healthcare market. Co. sells its products and services to a client base comprised of scientific research, healthcare, education and government customers.

When researching a stock like Bio-Rad Laboratories, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from BIO Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for BIO stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
BIO DMABIO MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bio-Rad Laboratories (BIO) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

BMY Technical Analysis
BSX Technical Analysis
CAH Technical Analysis
CI Technical Analysis
CNC Technical Analysis
COO Technical Analysis
CRL Technical Analysis
CTLT Technical Analysis
CVS Technical Analysis
DGX Technical Analysis
More Healthcare companies »

 

BIO Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2022, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.